SCHEMBL4915969

SCHEMBL4915969

CCOC(=O)C1[C]Oc2ccccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.48
POLB P06746 1/20 0.46
ALDH1A1 P00352 3/20 0.44
KMT2A Q03164 7/20 0.42
MEN1 O00255 6/20 0.42
CYP1A2 P05177 2/20 0.42
LMNA P02545 1/20 0.42
CHRM2 P08172 1/20 0.42
CYP2D6 P10635 1/20 0.42
CHRM1 P11229 1/20 0.42
KCNH2 Q12809 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ATM Q13315 1/20 0.41
USP2 O75604 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5255318 0.83 KMT2A (0.37) POLBALDH1A1KMT2AMEN1CYP1A2
SCHEMBL3374181 0.75 CYP2C9 (0.40) POLBALDH1A1KMT2AMEN1CYP1A2
SCHEMBL595243 0.74 ATM (0.69) TSHRPOLBALDH1A1KMT2AMEN1
SCHEMBL7907173 0.71 POLB (0.57) TSHRPOLBKMT2AMEN1CYP1A2
SCHEMBL9128468 0.70 ALDH1A1 (0.54) TSHRPOLBALDH1A1KMT2AMEN1
SCHEMBL32687865 0.70 ALDH1A1 (0.54) TSHRPOLBALDH1A1KMT2AMEN1
SCHEMBL4918721 0.70 KMT2A (0.33) TSHRPOLBKMT2AMEN1CYP1A2
SCHEMBL18740900 0.70 POLB (0.46) TSHRPOLBALDH1A1KMT2AMEN1
SCHEMBL14193348 0.69 TSHR (0.54) TSHRPOLBALDH1A1KMT2AMEN1
SCHEMBL4822281 0.69 TSHR (0.54) TSHRPOLBALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200475-A1 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors PFIZER INC. 2008-08-21 US disclosed
EP-1866317-A1 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2007-12-19 EP disclosed
WO-2006103555-A1 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200475-A1 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors PF4, TBXA2R, P2RY4 TSHR 337/4885POLB 1500/4885ALDH1A1 849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.